Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology:: A population-based, 5-year follow-up study

被引:219
作者
Molano, M
van den Brule, A
Plummer, M
Weiderpass, E
Posso, H
Arslan, A
Meijer, CJLM
Muñoz, N
Franceschi, S
机构
[1] Int Agcy Res Canc, F-69372 Lyon 08, France
[2] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands
[3] Inst Nacl Cancerol, Div Invest, Bogota, Colombia
关键词
cervix neoplasms; cohort studies; cytology; oral contraceptives; papillomavirus;
D O I
10.1093/aje/kwg171
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Little is known about the factors that influence clearance of human papillomavirus (HPV), the primary cause of cervical carcinoma. A total of 227 women cytologically normal and HPV positive at baseline were identified from a population-based cohort of 1,995 Bogota, Colombia, women aged 13-85 years followed between 1993 and 2000 (mean follow-up, 5.3 years). HPV DNA detection and viral load determination were based on a GP5+/GP6+ polymerase chain reaction enzyme immunoassay. Rate ratio estimates for HPV clearance were calculated by using methods for interval-censored survival time data. Analyses were based on 316 type-specific HPV infections. HPV 16 had a significantly lower clearance rate than infections with low-risk types (rate ratio (RR)=0.47, 95% confidence interval (CI): 0.32, 0.72), HPV types related to HPV 16 (types 31, 33, 35, 52, 58) had intermediate clearance rates (RR=0.62, 95% CI: 0.47, 0.94), and other high-risk types did not show evidence of slower clearance compared with low-risk types. Infections with single and multiple HPV types had similar clearance rates. There was no evidence of a dose-response relation between clearance and viral load. Observed was slower clearance in parous women (RR=0.64, 95% CI: 0.47, 0.89) and faster clearance in ever users of oral contraceptives (RR=1.38, 95% CI: 1.07, 1.77).
引用
收藏
页码:486 / 494
页数:9
相关论文
共 61 条
  • [51] Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CINII/III and viral clearance
    van Duin, M
    Snijders, PJF
    Schrijnemakers, HFJ
    Voorhorst, FJ
    Rozendaal, L
    Nobbenhuis, MAE
    van den Brule, AJC
    Verheijen, RHM
    Helmerhorst, TJ
    Meijer, CJLM
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (04) : 590 - 595
  • [52] RAPID DETECTION OF HUMAN PAPILLOMAVIRUS IN CERVICAL SCRAPES BY COMBINED GENERAL PRIMER-MEDIATED AND TYPE-SPECIFIC POLYMERASE CHAIN-REACTION
    VANDENBRULE, AJC
    MEIJER, CJLM
    BAKELS, V
    KENEMANS, P
    WALBOOMERS, JMM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (12) : 2739 - 2743
  • [53] Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia
    Villa, LL
    Sichero, L
    Rahal, P
    Caballero, O
    Ferenczy, A
    Rohan, T
    Franco, EL
    [J]. JOURNAL OF GENERAL VIROLOGY, 2000, 81 : 2959 - 2968
  • [54] Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt
  • [55] 12::AID-PATH431&gt
  • [56] 3.0.CO
  • [57] 2-F
  • [58] Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study
    Woodman, CBJ
    Collins, S
    Winter, H
    Bailey, A
    Ellis, J
    Prior, P
    Yates, M
    Rollason, TP
    Young, LS
    [J]. LANCET, 2001, 357 (9271) : 1831 - 1836
  • [59] ANALYSIS OF HUMAN PAPILLOMAVIRUS TYPE-16 VARIANTS INDICATES ESTABLISHMENT OF PERSISTENT INFECTION
    XI, LF
    DEMERS, GW
    KOUTSKY, LA
    KIVIAT, NB
    KUYPERS, J
    WATTS, DH
    HOLMES, KK
    GALLOWAY, DA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (03) : 747 - 755
  • [60] Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia
    Xi, LF
    Koutsky, LA
    Galloway, DA
    Kuypers, J
    Hughes, JP
    Wheeler, CM
    Holmes, KK
    Kiviat, NB
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (11): : 796 - 802